More nonsense. Top tier companies won't deal with Elite because they have a profit split on one product? Less then 10% of their pipeline?
Keep trying....
Nasrat gets his money when he sells the company. You think he's focused on Mikahs splits when he is going to make 300-500m in one sale of Elite? That's pretty funny
Are you serious? Do you know how much cash we will need for the new drugs API's these are very expensive drugs - do you want to be in a situation where you have 100 million worth of orders and can deliver only 20 million because you do not have enough cash to buy the API?
We have time to reimburse Mikah/Nasrat - why don't you throw a stock buy back while you are at it?
Market Data 
Markets 
AI
